Related Experiment Video
Updated: Feb 28, 2026

A Protein Preparation Method for the High-throughput Identification of Proteins Interacting with a Nuclear Cofactor Using LC-MS/MS Analysis
Published on: January 24, 2017
Competitive LC-MS/MS assay to investigate protein metalation dynamics
Kira Küssner1, Michael Wolf2,3, Andrea Cucchiaro1
1Institute for Pharmacy, Pharmaceutical Chemistry, Department of Chemistry and Pharmacy, Center for Molecular Bioscience (CMBI), University of Innsbruck Innrain 80/82 A-6020 Innsbruck Austria monika.cziferszky@uibk.ac.at.
This study developed a rapid assay to track how metallodrugs interact with proteins, revealing metal-specific binding and deactivation. Metallodrug reactivity is more selective in complex biological settings, offering new avenues for drug design.
Area of Science:
- Chemical Biology
- Medicinal Chemistry
- Biochemistry
Background:
- Metallodrugs show promise but their reactivity and toxicity are often generalized due to knowledge gaps in biospeciation.
- Understanding metallodrug interactions with biomolecules is crucial for their pharmaceutical development.
Purpose of the Study:
- To develop a rapid assay for determining metallodrug-protein interactions in competitive biological environments.
- To investigate the time-dependent reactivity and selectivity of platinum(II), ruthenium(II), and iridium(III) metallodrugs with protein mixtures.
Main Methods:
- A rapid and competitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay was developed.
- Time-dependent reactivity of metallodrugs with an equimolar protein mixture was analyzed.
- Online top-down fragmentation was used for binding site localization.
Main Results:
- The assay revealed metal-dependent selectivity in adduct formation and deactivation by nucleophiles like glutathione (GSH).
- Platinum(II) derivatives showed high reactivity with sulfur donors, while ruthenium(II) compounds preferred N-donor coordination (histidine residues).
- Iridium(III) compounds formed adducts with GSH, indicating rapid transformation via redox activity.
Conclusions:
- Metallodrug reactivity is more selective in competitive biological settings than previously assumed.
- Intracellular selectivity of metallodrugs can be chemically tuned, guiding future metallodrug design.
- The developed assay can be expanded to mimic physiological environments for more accurate metallodrug design.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
09:51Standards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MS
Published on: April 13, 2016